TrialRadiation oncology (London, England)2015

Intratumoral and peritumoral post-irradiation changes, but not viable tumor tissue, may respond to bevacizumab in previously irradiated meningiomas.

Motomasa Furuse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.